Shuttle Pharmaceuticals Plunges 24.66% on Reverse Stock Split Announcement

On June 12, 2025, Shuttle's stock price plummeted by 24.66% during pre-market trading, marking a significant downturn in its market performance.

Shuttle Pharmaceuticals has announced a proposed 25-for-1 reverse stock split, which has been approved by its Board of Directors. This strategic move aims to reduce the number of outstanding shares from 26.2 million to approximately 1.04 million, thereby strengthening the company's compliance with Nasdaq listing requirements. The reverse split will automatically combine every 25 shares of the company's common stock into one share, affecting both issued and outstanding shares as well as those that are issuable.

This decision comes as part of Shuttle Pharmaceuticals' efforts to enhance its financial stability and market position. The reverse stock split is expected to have a positive impact on the company's stock price by reducing the number of shares in circulation, which could potentially attract more investors and improve liquidity. However, the immediate market reaction has been negative, with investors likely concerned about the implications of such a significant reduction in share count.